Literature DB >> 6955305

A one-step purification of membrane proteins using a high efficiency immunomatrix.

C Schneider, R A Newman, D R Sutherland, U Asser, M F Greaves.   

Abstract

A method is described by which an immunoaffinity matrix was constructed by binding antibody directly or indirectly to protein A-Sepharose 4B followed by cross-linking of the complex with dimethyl pimelimidate. This allows optimal spatial orientation of antibodies and, thus, maximum antigen binding efficiency. The affinity matrices were stable to high and low pH buffers without any significant antibody loss. The optimal conditions of antibody saturation, cross-linker concentration, and elution system were established and affinity columns made with the monoclonal antibodies J5, W6/32, and OKT9 for one-step isolation of the common acute lymphoblastic leukemia-associated antigen, HLA-AB antigens, and transferrin receptor, respectively, from cell lysates. The same methodology was also applied to immobilize transferrin with polyvalent anti-transferrin antibodies. This was then used to isolate the transferrin receptor from cell lysates.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6955305

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  204 in total

1.  Proteasome subunit zeta, a putative ribonuclease, is also found as a free monomer.

Authors:  L Jørgensen; K B Hendil
Journal:  Mol Biol Rep       Date:  1999-04       Impact factor: 2.316

2.  Synthesis and assembly of connexins in vitro into homomeric and heteromeric functional gap junction hemichannels.

Authors:  S Ahmad; J A Diez; C H George; W H Evans
Journal:  Biochem J       Date:  1999-04-15       Impact factor: 3.857

Review 3.  Immunoaffinity chromatography.

Authors:  Anuradha Subramanian
Journal:  Mol Biotechnol       Date:  2002-01       Impact factor: 2.695

4.  The Mex67p-mediated nuclear mRNA export pathway is conserved from yeast to human.

Authors:  J Katahira; K Strässer; A Podtelejnikov; M Mann; J U Jung; E Hurt
Journal:  EMBO J       Date:  1999-05-04       Impact factor: 11.598

5.  Interleukin-1β-induced barrier dysfunction is signaled through PKC-θ in human brain microvascular endothelium.

Authors:  Robert R Rigor; Richard S Beard; Olesya P Litovka; Sarah Y Yuan
Journal:  Am J Physiol Cell Physiol       Date:  2012-03-07       Impact factor: 4.249

6.  Topology of the plastid Ndh complex and its NDH-F subunit in thylakoid membranes.

Authors:  Leonardo M Casano; H Ramiro Lascano; Mercedes Martín; Bartolomé Sabater
Journal:  Biochem J       Date:  2004-08-15       Impact factor: 3.857

7.  Arabidopsis ERG28 tethers the sterol C4-demethylation complex to prevent accumulation of a biosynthetic intermediate that interferes with polar auxin transport.

Authors:  Alexis Samba Mialoundama; Nurul Jadid; Julien Brunel; Thomas Di Pascoli; Dimitri Heintz; Mathieu Erhardt; Jérôme Mutterer; Marc Bergdoll; Daniel Ayoub; Alain Van Dorsselaer; Alain Rahier; Paul Nkeng; Philippe Geoffroy; Michel Miesch; Bilal Camara; Florence Bouvier
Journal:  Plant Cell       Date:  2013-12-10       Impact factor: 11.277

8.  Nck beta interacts with tyrosine-phosphorylated disabled 1 and redistributes in Reelin-stimulated neurons.

Authors:  Albéna Pramatarova; Pawel G Ochalski; Kelian Chen; Andrea Gropman; Sage Myers; Kyung-Tai Min; Brian W Howell
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

9.  Mass spectrometry-based identification of native cardiac Nav1.5 channel α subunit phosphorylation sites.

Authors:  Céline Marionneau; Cheryl F Lichti; Pierre Lindenbaum; Flavien Charpentier; Jeanne M Nerbonne; R Reid Townsend; Jean Mérot
Journal:  J Proteome Res       Date:  2012-11-09       Impact factor: 4.466

10.  Purification and partial amino acid sequence of suppressive lymphokine from a CD8+ CD57+ human T hybridoma.

Authors:  C P Quan; S Watanabe; F Vuillier; R Pires; T Matsuo; M Stanislawski; J Pillot; J P Bouvet
Journal:  Immunology       Date:  1993-02       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.